What Does Jacob Gottlieb’s Collaboration With Stuart Watson Mean For Healthcare Investment?

Jacob Gottlieb and Stuart Watson, two of the most experienced healthcare and investment experts, recently announced plans to have their two outfits operate under one roof. In the announcement, the two stated that Altium Capital was moving in with Watson’s Iguana capital partners where they would share office space. The fact that this isn’t the first time the two come together has far-reaching ramifications for the healthcare investment industry. But what can investors and sector players expect?

Well-performing hedge fund

The last time the two shared office space, they helped their investors realize up to 100 percent returns on investments. They would also carry on with their winning streaks even as separate entities where Gottlieb steered an $8 billion hedge fund with Watson heading the ever successful Iguana healthcare partners. With their hint about collaborating on a project in the near future, healthcare investors can now afford a smile.

A boost in healthcare technology

Since the age of Merlin, Stuart and Gottlieb have always channeled most of their attention towards the biotechnology industry. They are particularly interested in investing in healthcare IT, medical device and biotechnology startups. Industry players aligned to these sectors can, therefore, look forward to prompt access to funding as well as more informed guidance from some of the industries most experienced players.

Possible hedge fund partnerships

While the two haven’t explicitly stated the sort of collaboration they hope to push forward, all factors hint out to the establishment of a bigger investment vehicle. Investors can therefore either expect a launch of a third investment firm separate from Iguana and Altium or the merger between the two companies to form a more formidable asset management company.

Bottom line

Past collaborations and independent career runs have proven the efficiency of Gottlieb and Watson either individually or when they come together. Healthcare investors and other industry players, therefore, have a reason to remain hopeful as the two come together to experts forge a new front.

Leave a Reply

Your email address will not be published. Required fields are marked *